Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Net income	$ 23,145	$ 21,559
Adjustments to reconcile net income to cash provided by operating activities:
Amortization expense	2,021	1,786
Amortization of deferred financing costs	179	237
Share-based compensation	13,823	187
Deferred income taxes	(390)	(15)
(Increase) decrease in operating assets:
Commissions and fees receivable	190	(592)
Income tax receivable	572	(705)
Prepaid expenses and other current assets	536	(152)
Deferred financing asset	0	(36)
Increase (decrease) in operating liabilities:
Accounts payable	854	1,374
Commissions payable	2,329	2,338
Income tax payable	75	(4,781)
Accrued expenses	70	1,764
Net cash provided by operating activities	43,404	22,964
Cash flows from investing activities:
Internally developed software	(2,171)	(1,884)
Net cash used in investing activities	(2,171)	(1,884)
Cash flows from financing activities:
Change in fiduciary receivables	(1,353)	(831)
Change in fiduciary liabilities	28,334	26,615
Proceeds from 2025 Term Loan	0	301,000
Proceeds from revolving credit facility	24,000	0
Repayments of revolving credit facility	(24,000)	0
Repurchase of common stock	(31,869)	0
Payment of deferred financing fees and prepayment penalty	0	(477)
Proceeds from exercise of stock options	1,837	0
Taxes paid related to net share settlement of equity awards	(1,684)	0
Cash dividend paid	0	(175,000)
Net cash provided by (used in) financing activities	(4,735)	9,307
Net increase in cash and cash equivalents and fiduciary cash	36,498	30,387
Cash and cash equivalents and fiduciary cash:
Beginning of period	40,548	28,065
End of period	77,046	58,452
Cash and cash equivalents	17,553	11,697
Fiduciary cash	59,493	46,755
Total cash and cash equivalents and fiduciary cash	77,046	58,452
2024 Credit Agreement
Cash flows from financing activities:
Repayments of Term Loan	0	(135,000)
2025 Credit Agreement
Cash flows from financing activities:
Repayments of Term Loan	$ 0	$ (7,000)